Literature DB >> 17499470

Validated HPLC-MS/MS method for determination of quetiapine in human plasma.

B Barrett1, M Holcapek, J Huclová, V Borek-Dohalský, P Fejt, B Nemec, I Jelínek.   

Abstract

A validated, highly sensitive and selective high-pressure liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for the quantitative determination of quetiapine (QUE) in human Na2EDTA plasma with mass spectrometry (MS) detection. Clozapine (CLO) was employed as an internal standard. Samples were extracted using solid phase extraction (SPE). Oasis HLB cartridges and the concentration of quetiapine was determined by isocratic HPLC-MS/MS. The SRM mode was used for MS/MS detection. The method was validated over a concentration range of 1.0-382.2 ng/mL. Inter- and intra-day precision and accuracy of the proposed method were characterized by relative standard deviation (R.S.D.) and the percentage of deviation, respectively; both were lower than 8%. The developed method was employed in the pharmacokinetic study of quetiapine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499470     DOI: 10.1016/j.jpba.2007.03.034

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form.

Authors:  Rakshit Kanubhai Trivedi; Mukesh C Patel
Journal:  Sci Pharm       Date:  2011-01-16

2.  A rapid LC-MS/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study.

Authors:  Xiujuan Chen; Chen Liang; Lijun Cui; Jian Le; Zheyuan Qian; Runsheng Zhang; Zhanying Hong; Yifeng Chai
Journal:  J Food Drug Anal       Date:  2018-08-14       Impact factor: 6.157

3.  Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles.

Authors:  Xiaomei Huang; Suhua Zhang; Yanxia Ma; Heng Yang; Chuan He; Rufang Tian; Han Mei; Lipeng Liu; Bikui Zhang
Journal:  Drug Des Devel Ther       Date:  2018-12-31       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.